MyAverix Finance
F · Healthcare
EVOTEC SE ADR 1/2 O.N. (EVTA)
Drug Manufacturers - Specialty & Generic
EVOTEC SE ADR 1/2 O.N. (EVTA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $742.28M, P/E ratio is 18.00, net margin is -21.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EVTA
EVOTEC SE ADR 1/2 O.N. (EVTA) — FAQ
What is EVOTEC SE ADR 1/2 O.N.'s market cap?
EVOTEC SE ADR 1/2 O.N. (EVTA) has a reported market cap of $742.28M (data as of 2026-03-29).
What is EVTA's P/E ratio?
The price-to-earnings (P/E) ratio for EVOTEC SE ADR 1/2 O.N. (EVTA) is 18.00 (data as of 2026-03-29).
Does EVOTEC SE ADR 1/2 O.N. pay a dividend?
Dividend yield is not available in the current snapshot for EVOTEC SE ADR 1/2 O.N. (EVTA). Check the MyAverix Finance app for the latest dividend data.
What sector is EVOTEC SE ADR 1/2 O.N. in?
EVOTEC SE ADR 1/2 O.N. (EVTA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is EVTA listed on?
EVTA is listed on F.
What is EVOTEC SE ADR 1/2 O.N.'s net margin?
EVOTEC SE ADR 1/2 O.N. (EVTA) reports a net margin of -21.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.